# Evaluation of Dopaminergic Denervation by DaTSCAN Brain Scintigraphy Using a New Multipurpose CZT System

> **NCT04934046** · NA · TERMINATED · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 14 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **OTHER:** Additional acquisition

## Key facts

- **NCT ID:** NCT04934046
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-02
- **Primary completion:** 2022-12-02
- **Final completion:** 2022-12-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** As the team at Nancy University Hospital published the same study last year, on the competing CZT 3D system (Veriton), our study is no longer relevant.
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04934046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04934046, "Evaluation of Dopaminergic Denervation by DaTSCAN Brain Scintigraphy Using a New Multipurpose CZT System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04934046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*